Department of Biochemistry, Saarland University, Saarbrücken, Germany.
FEBS Lett. 2011 Jun 6;585(11):1506-13. doi: 10.1016/j.febslet.2011.04.035. Epub 2011 Apr 22.
The exploitation of cytochromes P450 for novel biotechnological application and for the investigation of their physiological function is of great scientific interest in this post genomic era, where an extraordinary biodiversity of P450 genes has been derived from all forms of life. The study of P450s in the myxobacterium Sorangium cellulosum strain So ce56, the producer of novel secondary metabolites of pharmaceutical interest is the research topic, in which we were engaged since the beginning of its genome sequencing project. We herein disclosed the cytochrome P450 complements (CYPomes) of spore-forming myxobacterial species, Stigmatella aurantiaca DW4/3-1, Haliangium ochraceum DSM 14365 and Myxococcus xanthus DK1622, and their potential pharmaceutical significance has been discussed.
在后基因组时代,细胞色素 P450 的开发对于新型生物技术应用和其生理功能的研究具有重要的科学意义。从各种生命形式中已经衍生出了异常丰富的 P450 基因多样性。我们的研究课题是粘细菌索莱里伯氏菌(Sorangium cellulosum)菌株 So ce56 中的细胞色素 P450,该菌是具有药物应用潜力的新型次级代谢产物的生产者。自该菌基因组测序项目开始以来,我们一直致力于此。本文揭示了形成孢子的粘细菌物种橙色着色菌(Stigmatella aurantiaca DW4/3-1)、黄杆菌(Haliangium ochraceum DSM 14365)和粘球菌(Myxococcus xanthus DK1622)的细胞色素 P450 基因簇(CYPomes),并讨论了它们的潜在药物意义。